Meeting the Challenges of Cytokine Administration During Nuclear Incident Response

View at publisher
Authors: Dana C. Tedesco, Suzanne Wright, Kenneth D. Cliffer, Neelima Yeddanapudi, Kimberly Kelley, Matt T. Clay, Shannon G. Loelius, John Esker, Mary J. Homer
Cited by: 1
References: 23

Abstract

Dr. C. Norman Coleman initiated the establishment of a working group within the Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services, to explore ways in which federal planning and guidance could better foster effective and efficient nuclear detonation response, with initial attention to cytokine use in the public health and medical response. Dr. Coleman recognized the difference between planning guidance (what to do) and a strategy (how to do it). He developed actionable strategies to improve our nation’s nuclear preparedness, including scarce resources triage protocols, 1 cytokine and evacuation priorities, 2 and the Exposure And Symptom Triage (EAST) tool. 3 Despite his absence and in his spirit, this working group, nicknamed “The Solutions Lab,” is continuing the work on actionable strategies for nuclear preparedness.

Fields of Study & Subjects

Disaster Response and Management Immune Response and Inflammation Bacillus and Francisella bacterial research

Publication details

Journal / source
Disaster Medicine and Public Health Preparedness
Publisher
Cambridge University Press (CUP)
Volume
20
Pages
e41–e41
Publication date
1 January 2026
Language
EN